These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36842551)

  • 1. Influence of social support and stressful life events on adherence to colorectal cancer screening using faecal occult blood test in Spanish medium risk population.
    Menéndez Rodríguez M; García-Morales N; Seoane Pillado T; Garau Ramírez J; Traver Salvador A; Hervás Jiménez Y; Fernández-Domínguez MJ; Menéndez Villalva C; Cubiella J
    Gastroenterol Hepatol; 2024 Jan; 47(1):14-23. PubMed ID: 36842551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived barriers and benefits in the participation in faecal occult blood test colorectal cancer screening programme.
    Menéndez Rodríguez M; García-Morales N; Seoane Pillado T; Garau Ramírez J; Traver Salvador A; Hervás Jiménez Y; Pin Vieito N; Menéndez Rodríguez L; Cubiella J
    Gastroenterol Hepatol; 2023 Mar; 46(3):185-194. PubMed ID: 35605825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rawl's questionnaire spanish validation for colorectal cancer screening with faecal occult blood testing.
    Menéndez Rodríguez M; Garau Ramírez J; Traver Salvador A; Hervás Jiménez Y; García Morales N; Seoane Pillado T; Pin Vieito N; Vega Villaamil P; Montes Martínez A; Cubiella J
    Gastroenterol Hepatol; 2022 Feb; 45(2):106-113. PubMed ID: 34023478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Socioeconomic Status and Adherence to Fecal Occult Blood Tests in Colorectal Cancer Screening Programs: Systematic Review and Meta-Analysis of Observational Studies.
    Luo Z; Dong X; Wang C; Cao W; Zheng Y; Wu Z; Xu Y; Zhao L; Wang F; Li J; Ren J; Shi J; Chen W; Li N
    JMIR Public Health Surveill; 2023 Oct; 9():e48150. PubMed ID: 37906212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Actitudes e imágenes sociales sobre el cribado de cáncer colorrectal. Una aproximación exploratoria mediante grupos de discusión.].
    de Haro Gázquez D; Fernández Sánchez B; Amador Muñoz ML
    Rev Esp Salud Publica; 2023 Aug; 97():. PubMed ID: 37970927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update.
    Cubiella J; Marzo-Castillejo M; Mascort-Roca JJ; Amador-Romero FJ; Bellas-Beceiro B; Clofent-Vilaplana J; Carballal S; Ferrándiz-Santos J; Gimeno-García AZ; Jover R; Mangas-Sanjuán C; Moreira L; Pellisè M; Quintero E; Rodríguez-Camacho E; Vega-Villaamil P;
    Gastroenterol Hepatol; 2018 Nov; 41(9):585-596. PubMed ID: 30245076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Educational Intervention Based on Health Belief Model and Social Support on the Rate of Participation of Individuals in Performing Fecal Occult Blood Test for Colorectal Cancer Screening.
    Gholampour Y; Jaderipour A; Khani Jeihooni A; Kashfi SM; Afzali Harsini P
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2777-2787. PubMed ID: 30360606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COLORECTAL CANCER: ASSOCIATION BETWEEN SOCIODEMOGRAPHIC VARIABLES AND THE ADHERENCE TO CANCER SCREENING.
    Kupper BEC; Ferreira FO; Nakagawa WT; Calsavara VF; Chulam TC; Lopes A; Aguiar-Junior S
    Arq Bras Cir Dig; 2023; 36():e1729. PubMed ID: 37194861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable Survival After Screening for Young-Onset Colorectal Cancer: Benefits of Screening in Young Adults.
    Takada K; Hotta K; Imai K; Ito S; Kishida Y; Ono H
    Dis Colon Rectum; 2022 Aug; 65(8):996-1004. PubMed ID: 34856591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
    Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ
    Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study.
    Castanon A; Parmar D; Massat NJ; Sasieni P; Duffy SW
    J Natl Cancer Inst; 2022 Sep; 114(9):1262-1269. PubMed ID: 35575409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to and predictors of participation in colorectal cancer screening with faecal occult blood testing in Spain, 2009-2011.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López-de-Andrés A
    Eur J Cancer Prev; 2015 Jul; 24(4):305-12. PubMed ID: 25304027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
    Ibáñez-Sanz G; Milà N; Vidal C; Rocamora J; Moreno V; Sanz-Pamplona R; Garcia M;
    PLoS One; 2021; 16(6):e0253369. PubMed ID: 34191813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.
    Denters MJ; Deutekom M; Fockens P; Bossuyt PM; Dekker E
    BMC Gastroenterol; 2009 Apr; 9():28. PubMed ID: 19393087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
    Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.